Population PKPD Analysis of CD4 and ACR Response after SC Administration of Tregalizumab to Patients with Rheumatoid Arthritis PAGE 25 (2016) Abstr 5708. Magnusson MO, Plan EL, Remy A, König M, Aigner S, Braun V, Zipp D, Zhou X, Wolter R, Schüttrumpf J, Wartenberg-Demand A, Dälken B, Rharbaoui F. ConferenceInflammationPharmacometricsProgram strategies and efficiencies Pharmetheus Affiliates Chief Operations Officer Mats Magnusson See bio Chief Business Development Officer & Deputy CEO Elodie Plan See bio